Lista de obras -

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

artículo científico publicado en 2014

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens

artículo científico publicado en 2003

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

artículo científico publicado en 2014

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

article

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

artículo científico publicado en 2017

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

artículo científico publicado en 2012

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure

artículo científico publicado en 2002

Did the coronavirus pandemic reveal old neglected infections?

artículo científico publicado en 2020

Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens

artículo científico publicado en 2010

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

article

Dynamics of NRTI Resistance Mutations during Therapy Interruption

article

Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy

article

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

artículo científico publicado en 2001

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

artículo científico publicado en 2015

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

artículo científico

HIV tropism and its relationship with transmitted resistance in naive patients

article

Historical resistance profile helps to predict salvage failure.

artículo científico

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.

artículo científico publicado en 2018

Implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic for sexual behaviours of men who have sex with men

artículo científico publicado en 2020

Is COVID-19 affecting the epidemiology of STIs? The experience of syphilis in Rome

artículo científico publicado en 2020

Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test

artículo científico publicado en 2010

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

artículo científico publicado en 2005

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

artículo científico publicado en 2004

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

artículo científico publicado en 2010

Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

artículo científico publicado en 2004

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

artículo científico publicado en 2014

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

artículo científico publicado en 2012

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

artículo científico publicado en 2004

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication

artículo científico publicado en 2014

Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.

artículo científico publicado en 2004

Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment

artículo científico publicado en 2018

Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals

article

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

artículo científico publicado en 2014

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

artículo científico publicado en 2014

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

artículo científico publicado en 2008

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

article

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

artículo científico publicado en 2015

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

artículo científico publicado en 2014

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

artículo científico publicado en 2016

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

article

The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?

artículo científico publicado en 2004

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

artículo científico publicado en 2003

Treatment-related factors and highly active antiretroviral therapy adherence

artículo científico publicado en 2002

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

artículo científico publicado en 2003

Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice

artículo científico publicado en 2017

Lista de obras de

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure

Did the coronavirus pandemic reveal old neglected infections?

Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

Dynamics of NRTI Resistance Mutations during Therapy Interruption

Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

HIV tropism and its relationship with transmitted resistance in naive patients

Historical resistance profile helps to predict salvage failure.

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.

Implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic for sexual behaviours of men who have sex with men

Is COVID-19 affecting the epidemiology of STIs? The experience of syphilis in Rome

Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication

Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.

Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment

Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

Treatment-related factors and highly active antiretroviral therapy adherence

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice